|
BBS10 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.635310E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.616430E-03 |
| Normal-vs-Stage2 |
4.041800E-02 |
| Normal-vs-Stage3 |
1.52073999999391E-05 |
| Normal-vs-Stage4 |
6.766200E-04 |
| Stage1-vs-Stage2 |
8.763200E-01 |
| Stage1-vs-Stage3 |
1.524450E-02 |
| Stage1-vs-Stage4 |
3.426000E-01 |
| Stage2-vs-Stage3 |
2.528400E-01 |
| Stage2-vs-Stage4 |
6.834600E-01 |
| Stage3-vs-Stage4 |
2.999800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.976100E-04 |
| Normal-vs-AfricanAmerican |
6.85069999950549E-07 |
| Normal-vs-Asian |
2.808400E-01 |
| Caucasian-vs-AfricanAmerican |
9.440600E-03 |
| Caucasian-vs-Asian |
7.781200E-01 |
| AfricanAmerican-vs-Asian |
1.679640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.031830E-04 |
| Normal-vs-Female |
1.977730E-03 |
| Male-vs-Female |
3.271200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.623550E-02 |
| Normal-vs-Age(41-60Yrs) |
2.758200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.51675999999767E-05 |
| Normal-vs-Age(81-100Yrs) |
1.681200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.580600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.372400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.712400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.990100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.349820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.877000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.028200E-01 |
| Normal-vs-Grade 2 |
1.502370E-02 |
| Normal-vs-Grade 3 |
3.88230000003542E-06 |
| Normal-vs-Grade 4 |
4.62469995632375E-09 |
| Grade 1-vs-Grade 2 |
8.500000E-01 |
| Grade 1-vs-Grade 3 |
2.384000E-01 |
| Grade 1-vs-Grade 4 |
1.412170E-02 |
| Grade 2-vs-Grade 3 |
3.292000E-02 |
| Grade 2-vs-Grade 4 |
2.09509999999913E-05 |
| Grade 3-vs-Grade 4 |
3.042600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.602630E-01 |
| Normal-vs-ccB subtype |
8.84680000035054E-07 |
| ccA subtype-vs-ccB subtype |
1.70663999999876E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.083890E-03 |
| Normal-vs-N1 |
3.870100E-02 |
| N0-vs-N1 |
6.898600E-01 |
|
|
